Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Tipo de estudo
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Mol Pharmacol ; 46(4): 612-7, 1994 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7969040

RESUMO

Purified assembly-competent vimentin, an intermediate filament protein, was obtained from bovine lens in this study. The effects of withangulatin A on vimentin assembly with or without phosphorylation were examined by negative-stain electron microscopy. Soluble tetrameric vimentin was assembled into irregular fibrils with lateral associations or short filaments after pretreatment with 50 or 100 microM withangulatin A, respectively. Incubation of assembled vimentin filaments with withangulatin A at 50 or 100 microM resulted in the formation of aggregates, and the degree of aggregation was concentration dependent. The appearance of vimentin filaments was slightly altered after treatment with cAMP-dependent protein kinase or protein kinase C; however, phosphorylation of filamentous vimentin by the protein kinases in the presence of withangulatin A resulted in higher degrees of aggregation of the filaments, compared with those treated only with the drug. Moreover, the level of phosphorylation of filamentous vimentin by the protein kinases was augmented in the presence of withangulatin A. Experimental results indicated that withangulatin A directly and specifically affects the conformation of the vimentin molecules, thereby resulting in alterations in assembly behavior and reactivity toward cAMP-dependent protein kinase and protein kinase C. The data observed further imply that withangulatin A, which directly causes aggregation of vimentin filaments, is a vimentin intermediate filament-targeting drug.


Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Medicamentos de Ervas Chinesas/farmacologia , Filamentos Intermediários/efeitos dos fármacos , Pregnenos/farmacologia , Proteína Quinase C/metabolismo , Vimentina/metabolismo , Animais , Bovinos , Técnicas In Vitro , Filamentos Intermediários/metabolismo , Filamentos Intermediários/ultraestrutura , Fosforilação , Vimentina/química
2.
J Cell Biochem ; 52(3): 253-65, 1993 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8366140

RESUMO

Withangulatin A induced cell rounding up and the morphological alteration resulted from the reorganization of all of the major cytoskeletal components, i.e., vimentin, tubulin, and actin, as revealed by immunofluorescence techniques. When the withangulatin A-treated cells changed to a round-up morphology, vimentin intermediate filaments were found to be collapsed and clustered around the nucleus. The alteration was accompanied by characteristic changes of vimentin molecules, including augmentation of phosphorylation, retardation of electrophoretic mobility, and decrease in detergent extractability. The levels of vimentin phosphorylation were augmented by 2.5- and 1.8-fold in cells incubated with 50 microM withangulatin A for 1 and 3 h, respectively. The electrophoretic mobility of vimentin was partially retarded in cells treated with withangulatin A for 1 h at 10 microM and a completely upshift mobility was observed after 5 h treatment at 50 microM. In addition, vimentin molecules became less extractable by nonident P-40 after the cells were treated with withangulatin A and this effect was dose dependent. The decrease in solubility of vimentin was accompanied by the redistribution of HSP72 into the detergent nonextractable fraction and these two events were well correlated. Our results suggest that withangulatin A induced the modification of vimentin, which resulted in the alteration of cell morphology and redistribution of intracellular HSP72, an event that may play an important role in the induction of heat-shock response.


Assuntos
Antineoplásicos/farmacologia , Neoplasias Encefálicas/patologia , Medicamentos de Ervas Chinesas , Proteínas de Choque Térmico/efeitos dos fármacos , Pregnenos/farmacologia , Vimentina/efeitos dos fármacos , Animais , Neoplasias Encefálicas/metabolismo , Tamanho Celular/efeitos dos fármacos , Citoesqueleto/efeitos dos fármacos , Detergentes , Proteínas de Choque Térmico/química , Proteínas de Choque Térmico/isolamento & purificação , Fosforilação , Ratos , Células Tumorais Cultivadas , Vimentina/química , Vimentina/isolamento & purificação , Vimentina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA